seed is the new drug
Why is all of a sudden early stage interesting for investors in Europe?
For once, it is more profitable - finding and backing startups at the earliest moment with the upside of becoming a multi billion dollar business is a really good business. It *is* the business.
Second reason is that series A/B round is getting really crowded in Europe.
We look into it.
Do you have a question? Talk to us.
Notes and commentaries about what matters in the European space - concise, no non-sense insights, interesting stories and implications for founders, investors, employees from tech companies or government representatives.
Published every Sunday morning by Dragos Novac and emailed to investors, founders and decisions makers from 50+ countries who want to understand the ecosystem from Europe.